Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RIPK1 | Q13546 | 2/20 | 0.35 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.35 |
| ▸ | USP21 | Q9UK80 | 2/20 | 0.30 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
| ▸ | CYP2C8 | P10632 | 1/20 | 0.30 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.30 |
| ▸ | ACHE | P22303 | 1/20 | 0.30 |
| ▸ | MAPKAPK5 | Q8IW41 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23009435 | 0.83 | DGAT1 (0.33) | RIPK1DGAT1 | |
| SCHEMBL23009522 | 0.83 | DGAT1 (0.43) | RIPK1DGAT1 | |
| SCHEMBL23009388 | 0.80 | DGAT1 (0.33) | RIPK1DGAT1USP21CYP3A4CYP2C8 | |
| SCHEMBL23009395 | 0.80 | DGAT1 (0.33) | DGAT1 | |
| SCHEMBL23009394 | 0.79 | DGAT1 (0.30) | DGAT1 | |
| SCHEMBL23009434 | 0.77 | DGAT1 (0.36) | RIPK1DGAT1 | |
| SCHEMBL23009404 | 0.77 | MME (0.31) | — | |
| SCHEMBL23009397 | 0.77 | DGAT1 (0.38) | RIPK1DGAT1 | |
| SCHEMBL15113210 | 0.74 | DGAT1 (0.38) | RIPK1DGAT1 | |
| SCHEMBL23009436 | 0.73 | DGAT1 (0.33) | RIPK1DGAT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210047354-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2021-02-18 | — | — | US | disclosed |
| EP-3778614-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | Universal Display Corporation (US) | 2021-02-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210047354-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | L1CAM, LEF1, EPCAM | RIPK1 4110/4885DGAT1 1546/4885USP21 4838/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.